Patents by Inventor SUSAN GAWEL

SUSAN GAWEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of insulin resistance associated with prolonged physical inactivity
    Patent number: 9713598
    Abstract: Insulin resistance biomarkers and related methods of using the biomarkers are provided. The biomarkers may be blood biomarkers and include C-peptide, Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2), and Leptin. Also provided is a method of reducing the effect of prolonged physical inactivity on insulin resistance in a subject who is experiencing prolonged physical inactivity, or who is expected to experience prolonged physical inactivity in the near future.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: July 25, 2017
    Assignee: ABBOTT LABORATORIES
    Inventors: Menghua Luo, Suzette Pereira, Neile Edens, Gerard Davis, Susan Gawel, Raj Chandran
  • TREATMENT OF INSULIN RESISTANCE ASSOCIATED WITH PROLONGED PHYSICAL INACTIVITY
    Publication number: 20160022617
    Abstract: Insulin resistance biomarkers and related methods of using the biomarkers are provided. The biomarkers may be blood biomarkers and include C-peptide, Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2), and Leptin. Also provided is a method of reducing the effect of prolonged physical inactivity on insulin resistance in a subject who is experiencing prolonged physical inactivity, or who is expected to experience prolonged physical inactivity in the near future.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Applicant: ABBOTT LABORATORIES
    Inventors: Menghua Luo, Suzette Pereira, Neile Edens, Gerard Davis, Susan Gawel, Raj Chandran
  • FIBROSIS BIOMARKERS AND METHODS OF USING SAME
    Publication number: 20150057350
    Abstract: Methods and systems for using fibrosis biomarkers associated with a prolonged period of physical inactivity are provided. Also provided is a method of reducing the effect of prolonged physical inactivity on the development of fibrosis in a subject who is experiencing or is expected to experience prolonged physical inactivity in the near future by administering a therapeutically effective amount of a leucine metabolite (e.g., ?-hydroxy-?-methylbutyric acid (HMB)) to the subject.
    Type: Application
    Filed: August 21, 2014
    Publication date: February 26, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: SUZETTE PEREIRA, MENGHUA LUO, NEILE EDENS, GERARD DAVIS, SUSAN GAWEL, RAJ CHANDRAN
  • METHODS OF MAINTAINING INTRAMUSCULAR MYOGLOBIN LEVELS, MAINTAINING MAXIMAL AEROBIC CAPACITY, AND ENHANCING THE OXIDATIVE CAPACITY OF MUSCLE IN A SUBJECT
    Publication number: 20150057346
    Abstract: Methods of maintaining intramuscular myoglobin levels, maintaining maximal aerobic capacity, and enhancing the oxidative capacity of muscle in a subject in need thereof are provided. Generally, the methods include administering an effective amount of ?-hydroxy-?-methylbutyrate to the subject. The ?-hydroxy-?-methylbutyrate may be administered as part of a nutritional composition.
    Type: Application
    Filed: August 21, 2014
    Publication date: February 26, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: BENJAMIN MEADOR, SUZETTE PEREIRA, NEILE EDENS, SUSAN GAWEL, RAJ CHANDRAN, GERARD DAVIS, MENGHUA LUO